Systematic Review of the Effectiveness of Parenteral Ketamine in Acute Agitation in Emergency Settings

Christopher Peter,Suhas Satish,Guru S Gowda,Deepak Ghadigaonkar,Krishna Prasad Muliyala,V. Senthil Kumar Reddi
DOI: https://doi.org/10.1016/j.ajp.2024.104344
IF: 13.89
2024-12-15
Asian Journal of Psychiatry
Abstract:Introduction Agitation is a significant psychiatric issue linked to conditions like schizophrenia, bipolar disorder, and major depression, prevalent in emergency settings. Acute agitation occurs in 2.6% of emergency cases and up to 12.2% among schizophrenia or bipolar patients. Ketamine is emerging as a fast-onset alternative to antipsychotics like haloperidol for managing this condition. Methods This systematic review, following PRISMA guidelines, searched databases in April 2024 for studies on parenteral ketamine for sedation in emergency psychiatric settings. Data extraction included patient demographics, ketamine administration details, sedation time, need for additional doses, adverse events, and intubation rates. Results The search yielded 7,410 results, narrowing to 29 suitable studies with 1,516 patients (mean age 35.5 ± 12.4 years, 67.9% male). Ketamine was administered intramuscularly (IM) in 69% of studies, intravenously (IV) in 6.9%, and either IV or IM in 24.1%. Most patients (86.5%) received IM ketamine at a mean dose of 3.83 ± 1.07 mg/kg, while 13.5% received IV ketamine at 2.09 ± 1.56 mg/kg. Sedation occurred on average in 6.1 minutes. However, 24.5% needed rescue medications or additional doses. Adverse effects included tachycardia, hypertension, hypersalivation, nausea, emergence reactions, and, rarely, cardiac arrest, with 19.1% requiring intubation. Conclusion This review highlights the effectiveness and safety of parenteral ketamine for managing acute agitation in emergency settings. Further research is needed to optimize ketamine use in this challenging scenario.
psychiatry
What problem does this paper attempt to address?